Renergen Limited (FRA:996)

Market Cap	72.68M
Revenue (ttm)	2.69M
Net Income (ttm)	-14.67M
Shares Out	n/a
EPS (ttm)	-0.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	325
Open	0.4600
Previous Close	0.4560
Day's Range	0.4300 - 0.4600
52-Week Range	0.1580 - 0.8500
Beta	n/a
RSI	46.20
Earnings Date	Jan 29, 2026

About Renergen

Renergen Limited, an investment holding company, engages in the alternative and renewable energy businesses in South Africa and sub-Saharan Africa. It operates through Tetra4 and Cryovation segments. The company explores for, develops, and sells liquefied natural gas and helium gas. It also develops Cryo-Vacc technology, which enables the transportation of vaccines and biologics at low temperature without any electrical power. Renergen Limited was founded in 2005 and is based in Sandton, South Africa.

• Industry: Crude Petroleum and Natural Gas
• Founded: 2005
• Employees: 35
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 996

Financial Performance

In 2024, Renergen's revenue was 52.11 million, an increase of 80.00% compared to the previous year's 28.95 million. Losses were -236.12 million, 114.1% more than in 2023.

Financial numbers in ZAR